Holen Sie sich die Stockscreener-App
11.55
3.59%
-0.43
Handel nachbörslich:
11.52
-0.03
-0.26%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt FMC?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$11.98
Offen:
$12
24-Stunden-Volumen:
8.19M
Relative Volume:
2.43
Marktkapitalisierung:
$1.44B
Einnahmen:
$3.43B
Nettoeinkommen (Verlust:
$-2.46B
KGV:
-0.577
EPS:
-20.0187
Netto-Cashflow:
$-204.10M
1W Leistung:
+2.48%
1M Leistung:
-14.76%
6M Leistung:
-15.26%
1J Leistung:
-72.25%
1-Tages-Spanne:
$11.06
$12.09
1-Wochen-Bereich:
$11.06
$12.67
52-Wochen-Spanne:
$10.72
$44.68
Fmc Corp Stock (FMC) Company Profile
Firmenname
Fmc Corp
Sektor
Branche
Telefon
215-299-6668
Adresse
2929 WALNUT STREET, PHILADELPHIA, PA
Compare FMC vs CTVA, NTR, CF, MOS, ICL
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FMC
Fmc Corp
|
11.55 | 1.44B | 3.43B | -2.46B | -204.10M | -20.02 |
CTVA
Corteva Inc
|
78.59 | 52.56B | 17.89B | 1.26B | 2.05B | 1.7029 |
NTR
Nutrien Ltd
|
62.86 | 30.17B | 27.83B | 2.42B | 2.21B | 4.9113 |
CF
Cf Industries Holdings Inc
|
102.93 | 15.81B | 7.41B | 2.12B | 1.62B | 11.13 |
MOS
Mosaic Company
|
22.90 | 7.28B | 12.05B | 575.40M | -534.60M | 1.6871 |
ICL
Icl Group Ltd
|
5.14 | 6.63B | 7.41B | 314.00M | 220.88M | 0.202 |
Fmc Corp Stock (FMC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-22 | Herabstufung | Vertical Research | Hold → Sell |
| 2025-12-09 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2025-11-11 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2025-10-31 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-10-31 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2025-06-23 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-04-25 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-03-13 | Eingeleitet | Goldman | Buy |
| 2025-02-14 | Herabstufung | Redburn Atlantic | Buy → Neutral |
| 2025-02-07 | Herabstufung | UBS | Buy → Neutral |
| 2025-02-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-01-21 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-01-14 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2024-10-23 | Eingeleitet | Citigroup | Neutral |
| 2024-06-26 | Eingeleitet | Barclays | Equal Weight |
| 2024-03-01 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-02-12 | Herabstufung | Loop Capital | Buy → Hold |
| 2024-02-07 | Herabstufung | Exane BNP Paribas | Outperform → Neutral |
| 2024-01-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-01-04 | Eingeleitet | ROTH MKM | Buy |
| 2023-12-14 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2023-12-07 | Herabstufung | Mizuho | Buy → Neutral |
| 2023-10-24 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-10-24 | Herabstufung | Goldman | Buy → Neutral |
| 2023-10-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-10-16 | Hochstufung | Vertical Research | Hold → Buy |
| 2023-09-25 | Herabstufung | Redburn Atlantic | Overweight → Neutral |
| 2023-09-05 | Herabstufung | UBS | Buy → Neutral |
| 2023-08-21 | Eingeleitet | JP Morgan | Neutral |
| 2023-08-04 | Hochstufung | Credit Suisse | Underperform → Neutral |
| 2023-07-24 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-17 | Hochstufung | Redburn | Neutral → Buy |
| 2023-01-19 | Fortgesetzt | Wells Fargo | Overweight |
| 2023-01-10 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-11-15 | Hochstufung | Loop Capital | Hold → Buy |
| 2022-07-20 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2022-06-21 | Hochstufung | BofA Securities | Underperform → Buy |
| 2022-06-13 | Herabstufung | Redburn | Buy → Neutral |
| 2022-05-31 | Eingeleitet | Credit Suisse | Underperform |
| 2022-04-14 | Herabstufung | Loop Capital | Buy → Hold |
| 2022-03-31 | Herabstufung | Monness Crespi & Hardt | Buy → Neutral |
| 2022-03-22 | Herabstufung | BofA Securities | Buy → Underperform |
| 2022-02-10 | Bestätigt | Citigroup | Buy |
| 2022-02-10 | Bestätigt | Mizuho | Buy |
| 2022-02-10 | Bestätigt | Monness Crespi & Hardt | Buy |
| 2022-02-10 | Bestätigt | Wells Fargo | Overweight |
| 2022-01-31 | Eingeleitet | Redburn | Buy |
| 2022-01-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-11-29 | Hochstufung | BofA Securities | Neutral → Buy |
| 2021-10-18 | Hochstufung | Loop Capital | Hold → Buy |
| 2021-10-13 | Eingeleitet | Mizuho | Buy |
| 2021-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2021-06-24 | Herabstufung | Vertical Research | Buy → Hold |
| 2021-05-06 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-02-11 | Hochstufung | Monness Crespi & Hardt | Neutral → Buy |
| 2020-09-17 | Eingeleitet | UBS | Buy |
| 2020-03-26 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-03-13 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-10-16 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2019-10-16 | Eingeleitet | Wells Fargo | Outperform |
| 2019-09-18 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2019-08-09 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2019-08-02 | Hochstufung | Goldman | Neutral → Buy |
| 2019-08-01 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-06-13 | Fortgesetzt | Citigroup | Buy |
| 2019-05-20 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2019-04-18 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2019-03-21 | Bestätigt | Jefferies | Buy |
| 2019-03-08 | Fortgesetzt | Goldman | Neutral |
| 2018-11-14 | Eingeleitet | Buckingham Research | Buy |
| 2018-11-09 | Fortgesetzt | Loop Capital | Buy |
| 2018-11-05 | Fortgesetzt | Citigroup | Buy |
| 2018-11-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2018-05-14 | Hochstufung | Goldman | Neutral → Buy |
| 2018-05-04 | Hochstufung | Stephens | Equal-Weight → Overweight |
Alle ansehen
Fmc Corp Aktie (FMC) Neueste Nachrichten
Why FMC’s Authority 3 herbicide is drawing growers’ attention - AD HOC NEWS
FMC Corp. Sale Decision Could Come This Summer for Philadelphia Pesticide Giant - PHILADELPHIA.Today
FMC Corp. stock underperforms Thursday when compared to competitors - MarketWatch
FMC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
FMC, Corteva to partner on herbicide technology supply and license deal - MSN
Quiet but potent, rimisoxafen from FMC puts stubborn weeds under pressure - AD HOC NEWS
FMC and Corteva Partner to Expand Access to Rimisoxafen Technology - Yahoo Finance Singapore
FMC Corp. stock outperforms competitors on strong trading day - MarketWatch
FMC boss says the company could be sold by July - Inquirer.com
FMC Up Nearly 9%, on Pace for Largest Percent Increase Since April 2025 -- Data Talk - Moomoo
FMC Corp (FMC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
FMC Corp (FMC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
FMC Corp. and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology - AgriBusiness Global
FMC Corp (FMC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
FMC Corp (FMC) Valuation: PE, PB & Fair Value Analysis - TradingKey
FMC Corp (FMC) Institutional Confidence - TradingKey
FMC Corp (FMC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
FMC Corp (FMC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
FMC Corp (FMC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
FMC and Corteva Sign Strategic Supply and License Agreement for Rimisoxafen Herbicide Technology - iGrow News
FMC Corp. (FMC) Partners with Corteva to Enhance Herbicide Techn - GuruFocus
FMC Enters Strategic Agreement to Expand Herbicide Technology Ac - GuruFocus
FMC, Corteva to partner on herbicide technology supply and license deal (FMC:NYSE) - Seeking Alpha
FMC and Corteva partner on herbicide technology distribution - Investing.com
FMC Corporation and Corteva Expand Access to Breakthrough Rimisoxafen Herbicide Technology - Financial Times
New biological label extension puts FMC’s Exirel insecticide in the spotlight - AD HOC NEWS
FMC Corp. stock underperforms Monday when compared to competitors - MarketWatch
FMC (FMC) CEO Brondeau reports tax-withholding of 34,177 vested shares - Stock Titan
FMC Corp. Stock (US3024913036): Valuation Comes Into Focus After Prolonged Downturn - AD HOC NEWS
FMC Corp. just agreed to sell its India commercial business. Here's what that means for the stock in 2026. - MSN
Is It Too Late to Buy FMC Corp (FMC) After 5.2% Rally? GF Value Says Undervalued - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
FMC Corp. Stock (US3024913036): Valuation back in focus after 2023 selloff - AD HOC NEWS
RBC Capital Maintains FMC Corp(FMC.US) With Hold Rating, Cuts Target Price to $14 - Moomoo
FMC stock hits 52-week low at 10.91 USD By Investing.com - Investing.com India
FMC Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
FMC Corp execs to speak at Wolfe Research Materials of the Future conference on June 17, 2026. - Pluang
FMC Corporation CEO Pierre Brondeau and CFO Andrew Sandifer to speak at Wolfe Research 3rd Annual Materials of the Future Conference - Stock Titan
FMC stock hits 52-week low at 10.91 USD - Investing.com
Wells Fargo Maintains FMC Corp(FMC.US) With Hold Rating, Maintains Target Price $17 - 富途牛牛
FMC Corp. stock (US3024913036): Agriculture player in focus after recent share price volatility - AD HOC NEWS
FMC Corp. stock (US3024913036): Crop protection group under pressure after guidance cut and dividend - AD HOC NEWS
FMC (FMC) Q3 2016 Earnings Call Transcript - MLQ.ai
If you'd invested in FMC stock 5 years ago, here's how much you'd have today (spoiler: it's not pretty) - MSN
FMC Corp. stock underperforms Friday when compared to competitors - MarketWatch
FMC (NYSE: FMC) issues $1.2B 8% senior secured notes to refinance debt - Stock Titan
FMC Corp. Just Agreed to Sell Its India Commercial Business. Here's What That Means for the Stock in 2026. - AOL.com
FMC receives EU approval for Isoflex herbicide active ingredient - Investing.com
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
FMC Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
FMC Corporation (FMC) and Other Stocks Earn Top Valuation Grades - GuruFocus
Finanzdaten der Fmc Corp-Aktie (FMC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.11%
1.57%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):